Cognition Therapeutics’ Small Molecule Soluble Abeta Oligomer Receptor Antagonist Program for Alzheimer’s Disease Selected for Support by National Institute on...

Cognition Therapeutics’ Small Molecule Soluble Abeta Oligomer Receptor Antagonist Program for Alzheimer’s Disease Selected for Support by National Institute on...

PITTSBURGH, April 1, 2014 /PRNewswire/ — Patent describes the discovery of several candidate drug molecules which can stop the effects of the brain protein that appears to...